FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Massimo Procopio

Research Profile

Chemicals & Drugs

Disorders

Physiology

Drug Synergism

Procedures

Glucose Tolerance Test

Concepts & Ideas

Co-author Network

Publications

TOP 3
Michele Zini; Roberto Attanasio; Jens Bollerslev; Giorgio Borretta; Roberto Cesareo; Ignazio Emmolo; Andrea Frasoldati; Laura Gianotti; Rinaldo Guglielmi; Claudio Marcocci; Alessandro Piovesan; Massimo Procopio; D. Sudhaker Rao; Alfredo Scillitani; Annibale Versari
AME position statement: primary hyperparathyroidism in clinical practice.
Gianluca Aimaretti; Ginevra Corneli; Silvia Rovere; C G Croce; Ezio Ghigo; Massimo Procopio
Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
Mauro Feola; Flavio Ribichini; Valeria Ferrero; Massimo Procopio; Gianpaolo Magro; Antonello Vado; Giorgio Borretta; Giacomo Boccuzzi; Corrado Vassanelli; Eugenio Uslenghi
Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Massimo Procopio (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michele Zini; Roberto Attanasio; Jens Bollerslev; Giorgio Borretta; Roberto Cesareo; Ignazio Emmolo; Andrea Frasoldati; Laura Gianotti; Rinaldo Guglielmi; Claudio Marcocci; Alessandro Piovesan; Massimo Procopio; D. Sudhaker Rao; Alfredo Scillitani; Annibale Versari
AME position statement: primary hyperparathyroidism in clinical practice.
Journal of endocrinological investigation 2012;35(7 Suppl):2-21.
2005: Gianluca Aimaretti; Ginevra Corneli; Silvia Rovere; C G Croce; Ezio Ghigo; Massimo Procopio
Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
Journal of endocrinological investigation 2005;28(10 Suppl):28-32.
2004: Mauro Feola; Flavio Ribichini; Valeria Ferrero; Massimo Procopio; Gianpaolo Magro; Antonello Vado; Giorgio Borretta; Giacomo Boccuzzi; Corrado Vassanelli; Eugenio Uslenghi
Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis.
The American journal of cardiology 2004;94(6):777-80.
2003: Massimo Procopio; Giorgio Borretta
Derangement of glucose metabolism in hyperparathyroidism.
Journal of endocrinological investigation 2003;26(11):1136-42.
2002: Massimo Procopio; Gianpaolo Magro; Flora Cesario; Alessandro Piovesan; Anna Pia; N Molineri; Giorgio Borretta
The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(11):958-61.
2002: Massimo Terzolo; Anna Pia; Anna Alì; Giangiacomo Osella; Giuseppe Reimondo; Silvia Bovio; Fulvia Daffara; Massimo Procopio; Piero Paccotti; Giorgio Borretta; Alberto Angeli
Adrenal incidentaloma: a new cause of the metabolic syndrome?
The Journal of clinical endocrinology and metabolism 2002;87(3):998-1003.
2002: Francesco Tassone; Ruth Rossetto; Carlotta Gauna; Massimo Procopio; Silvia Grottoli; L Ausiello; Marina Taliano; Mauro Maccario
Age-related endocrine and metabolic changes in simple obesity.
Journal of endocrinological investigation 2002;25(10 Suppl):106.
2001: Mauro Maccario; Francesco Tassone; Carlotta Gauna; SE Oleandri; Gianluca Aimaretti; Massimo Procopio; Silvia Grottoli; CD Pflaum; Christian J Strasburger; Ezio Ghigo
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH.
European journal of endocrinology / European Federation of Endocrine Societies 2001;144(3):251-6.
2000: Mauro Maccario; Silvia Grottoli; Massimo Procopio; SE Oleandri; Ruth Rossetto; Carlotta Gauna; Emanuela Arvat; Ezio Ghigo
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 2():S96-9.
1999: Massimo Procopio; Mauro Maccario; P Savio; MR Valetto; Gianluca Aimaretti; Silvia Grottoli; SE Oleandri; Claudia Baffoni; Francesco Tassone; Emanuela Arvat; Franco Camanni; Ezio Ghigo
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Minerva endocrinologica 1999;24(3-4):107-11.
1999: Mauro Maccario; Silvia Grottoli; Gianluca Aimaretti; Laura Gianotti; S Endrio Oleandri; Massimo Procopio; P Savio; Francesco Tassone; Josefina Ramunni; Franco Camanni; Ezio Ghigo
IGF-1 levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency.
Minerva endocrinologica 1999;24(2):57-61.
1999: Mauro Maccario; Carlotta Gauna; Massimo Procopio; Lidia Di Vito; Ruth Rossetto; SE Oleandri; Silvia Grottoli; Chiara Ganzaroli; Gianluca Aimaretti; Ezio Ghigo
Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.
Journal of endocrinological investigation 1999;22(6):424-9.
1999: Mauro Maccario; Josefina Ramunni; SE Oleandri; Massimo Procopio; Silvia Grottoli; Ruth Rossetto; P Savio; Gianluca Aimaretti; Franco Camanni; Ezio Ghigo
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(6):612-8.
1999: Cesare Carani; R Mantovani; Massimo Procopio; Graziano Del Rio; Ruth Rossetto; A R Granata
GH/IGF-I axis in azoospermia in primary and secondary hypogonadism: a study before and during replacement therapy.
International journal of andrology 1999;22(3):184-9.
1999: Mauro Maccario; E Mazza; Josefina Ramunni; SE Oleandri; P Savio; Silvia Grottoli; Ruth Rossetto; Massimo Procopio; Carlotta Gauna; Ezio Ghigo
Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women.
Clinical endocrinology 1999;50(5):595-600.
1999: SE Oleandri; Mauro Maccario; Ruth Rossetto; Massimo Procopio; Silvia Grottoli; Enrico Avogadri; Carlotta Gauna; Chiara Ganzaroli; Ezio Ghigo
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.
Journal of endocrinological investigation 1999;22(2):134-40.
1998: Mauro Maccario; Silvia Grottoli; Gianluca Aimaretti; Laura Gianotti; S Endrio Oleandri; Massimo Procopio; P Savio; Francesco Tassone; Josefina Ramunni; Franco Camanni; Ezio Ghigo
IGF-I levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency.
Panminerva medica 1998;40(2):98-102.
1998: Massimo Procopio; Mauro Maccario; P Savio; MR Valetto; Gianluca Aimaretti; Silvia Grottoli; SE Oleandri; Claudia Baffoni; Francesco Tassone; Emanuela Arvat; Franco Camanni; Ezio Ghigo
GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Panminerva medica 1998;40(1):13-7.
1998: Mauro Maccario; SE Oleandri; Enrico Avogadri; Ruth Rossetto; Silvia Grottoli; Massimo Procopio; Franco Camanni; Ezio Ghigo
Effects of 3-month nifedipine treatment on endocrine-metabolic parameters in patients with abdominal obesity and mild hypertension.
Journal of endocrinological investigation 1998;21(1):56-63.
1998: Mauro Feola; G M Boffano; Massimo Procopio; S Reynaud; P Allemano; G Rizzi
Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Giornale italiano di cardiologia 1998;28(1):38-44.
1997: Graziano Del Rio; Massimo Procopio; Mario Bondi; P Marrama; Renata Menozzi; SE Oleandri; Silvia Grottoli; Mauro Maccario; A Velardo; Ezio Ghigo
Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(12):1111-4.
1997: Mauro Maccario; SE Oleandri; Massimo Procopio; Silvia Grottoli; Enrico Avogadri; Franco Camanni; Ezio Ghigo
Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in man.
Journal of endocrinological investigation 1997;20(8):488-92.
1997: Silvia Grottoli; Massimo Procopio; Mauro Maccario; MG Zini; SE Oleandri; Francesco Tassone; Roberto Valcavi; Ezio Ghigo
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
The Journal of clinical endocrinology and metabolism 1997;82(7):2261-5.
1997: Mauro Maccario; Silvia Grottoli; Massimo Procopio; SE Oleandri; G M Boffano; P Savio; Franco Camanni; Ezio Ghigo
Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity.
Journal of endocrinological investigation 1997;20(1):8-12.
1997: Mauro Maccario; MR Valetto; P Savio; Gianluca Aimaretti; Claudia Baffoni; Massimo Procopio; Silvia Grottoli; SE Oleandri; Emanuela Arvat; Ezio Ghigo
Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1997;21(1):27-32.
1996: Silvia Grottoli; Mauro Maccario; Massimo Procopio; SE Oleandri; Emanuela Arvat; Laura Gianotti; Romano Deghenghi; Franco Camanni; Ezio Ghigo
Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(6):678-82.
1996: Graziano Del Rio; Cesare Carani; A Velardo; Massimo Procopio; G Zizzo; P Savio; R Mantovani; P Marrama; Ezio Ghigo
The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy.
Journal of endocrinological investigation 1996;19(8):505-10.
1996: Mauro Maccario; Silvia Grottoli; Paola Razzore; Massimo Procopio; SE Oleandri; Enrica Ciccarelli; Franco Camanni; Ezio Ghigo
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(2):205-10.
1996: Mauro Maccario; Silvia Grottoli; Massimo Procopio; SE Oleandri; A Barberis; Enrica Ciccarelli; Franco Camanni; Ezio Ghigo
Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity.
Journal of endocrinological investigation 1996;19(4):219-23.
1996: Mauro Maccario; Massimo Procopio; Silvia Grottoli; SE Oleandri; G M Boffano; M Taliano; Franco Camanni; Ezio Ghigo
Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.
Metabolism: clinical and experimental 1996;45(3):342-6.
1995: Massimo Procopio; Mauro Maccario; Silvia Grottoli; SE Oleandri; G M Boffano; Franco Camanni; Ezio Ghigo
Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Clinical endocrinology 1995;43(6):665-9.
1995: Mauro Maccario; Massimo Procopio; Silvia Grottoli; SE Oleandri; Paola Razzore; Franco Camanni; Ezio Ghigo
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
The Journal of clinical endocrinology and metabolism 1995;80(12):3774-8.
1995: Graziano Del Rio; Cesare Carani; A Velardo; G Zizzo; Massimo Procopio; F Coletta; P Marrama; Ezio Ghigo
Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism.
Journal of endocrinological investigation 1995;18(9):690-5.
1995: Massimo Procopio; Cecilia Invitti; Mauro Maccario; Silvia Grottoli; Francesco Cavagnini; Franco Camanni; Ezio Ghigo
Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19(2):108-12.
1995: Mauro Maccario; Emanuela Arvat; Massimo Procopio; Laura Gianotti; Silvia Grottoli; BP Imbimbo; Vincent Lenaerts; Romano Deghenghi; Franco Camanni; Ezio Ghigo
Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.
Metabolism: clinical and experimental 1995;44(1):134-8.
1995: Valentino Martina; Guido Albino Bruno; Milena Tagliabue; S Bertaina; Mauro Maccario; Silvia Grottoli; Massimo Procopio; alessandro ozzello; Franco Camanni
Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1995;27(1):26-30.
1994: E Mazza; Ezio Ghigo; G Boffano; MR Valetto; Mauro Maccario; Emanuela Arvat; Jaele Bellone; Massimo Procopio; Eugenio E Müller; Franco Camanni
Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans.
European journal of pharmacology 1994;254(1-2):17-20.
1994: Mauro Maccario; Massimo Procopio; Sandro Loche; Marco Cappa; Valentino Martina; Franco Camanni; Ezio Ghigo
Interaction of free fatty acids and arginine on growth hormone secretion in man.
Metabolism: clinical and experimental 1994;43(2):223-6.
1993: Roberto Valcavi; F Valente; C Dieguez; MG Zini; Massimo Procopio; I Portioli; Ezio Ghigo
Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
The Journal of clinical endocrinology and metabolism 1993;77(3):616-20.
1993: Emanuela Arvat; Laura Gianotti; S Goffi; Mauro Maccario; Jaele Bellone; Massimo Procopio; Franco Camanni; Ezio Ghigo
[Neuroregulation of GH secretion in aging].
Minerva endocrinologica 1993;18(3 Suppl 1):14-20.
1993: Ezio Ghigo; Massimo Procopio; Mauro Maccario; Jaele Bellone; Emanuela Arvat; S Campana; MF Boghen; Franco Camanni
Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1993;25(6):305-8.
1993: Jaele Bellone; Ezio Ghigo; Massimo Procopio; Emanuela Arvat; F Valente; G M Boffano; Mauro Maccario; Patrizia Dentelli; Franco Camanni
Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children.
Panminerva medica 1993;35(1):1-4.
1992: Ezio Ghigo; Aldo Miola; Gianluca Aimaretti; F Valente; Massimo Procopio; Emanuela Arvat; W Yin-Zhang; Franco Camanni
Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man.
Metabolism: clinical and experimental 1992;41(9):1000-3.
1992: Ezio Ghigo; Massimo Procopio; G M Boffano; Emanuela Arvat; F Valente; Mauro Maccario; E Mazza; Franco Camanni
Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity.
Metabolism: clinical and experimental 1992;41(5):560-3.
1991: Ezio Ghigo; Emanuela Arvat; F Valente; M Nicolosi; G M Boffano; Massimo Procopio; Jaele Bellone; Mauro Maccario; E Mazza; Franco Camanni
Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults.
Neuroendocrinology 1991;54(3):291-4.
1991: Ezio Ghigo; Massimo Procopio; Jaele Bellone; E Mazza; M Mucci; MF Boghen; Eugenio E Müller; Franco Camanni
Intranasal administration of neostigmine potentiates both intravenous and intranasal growth hormone (GH)-releasing hormone-induced GH release in short children.
The Journal of clinical endocrinology and metabolism 1991;72(2):467-70.
1990: Ezio Ghigo; Emanuela Arvat; M Nicolosi; Jaele Bellone; MR Valetto; E Mazza; E Imperiale; Massimo Procopio; M C Ghigo; Franco Camanni
Acute clonidine administration potentiates spontaneous diurnal, but not nocturnal, growth hormone secretion in normal short children.
The Journal of clinical endocrinology and metabolism 1990;71(2):433-5.
1990: Ezio Ghigo; S Goffi; Emanuela Arvat; M Nicolosi; Massimo Procopio; Jaele Bellone; E Imperiale; E Mazza; G Baracchi; Franco Camanni
Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging.
Acta endocrinologica 1990;123(2):169-73.
1990: Ezio Ghigo; Jaele Bellone; E Mazza; E Imperiale; Massimo Procopio; F Valente; Roberto Lala; Carlo de Sanctis; Franco Camanni
Arginine potentiates the GHRH- but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatin suppressing effect of arginine.
Clinical endocrinology 1990;32(6):763-7.
1990: Ezio Ghigo; E Imperiale; G M Boffano; E Mazza; Jaele Bellone; Emanuela Arvat; Massimo Procopio; S Goffi; A Barreca; P Chiabotto
A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Journal of endocrinological investigation 1990;13(4):307-16.
1990: Ezio Ghigo; E Mazza; Jaele Bellone; Emanuela Arvat; E Imperiale; Massimo Procopio; Franco Camanni
Neuroactive drugs in growth disorders.
Acta paediatrica Scandinavica. Supplement 1990;367():33-7.
1989: E Mazza; Ezio Ghigo; S Goffi; Massimo Procopio; E Imperiale; Emanuela Arvat; Jaele Bellone; MF Boghen; Eugenio E Müller; Franco Camanni
Effect of the potentiation of cholinergic activity on the variability in individual GH response to GH-releasing hormone.
Journal of endocrinological investigation 1989;12(11):795-8.
1989: Ezio Ghigo; S Goffi; E Mazza; Emanuela Arvat; Massimo Procopio; Jaele Bellone; Eugenio E Müller; Franco Camanni
Repeated GH-releasing hormone administration unravels different GH secretory patterns in normal adults and children.
Acta endocrinologica 1989;120(5):598-601.
1989: Ezio Ghigo; S Goffi; E Mazza; E Imperiale; Emanuela Arvat; Jaele Bellone; Massimo Procopio; Eugenio E Müller; Franco Camanni
Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children.
Journal of endocrinological investigation 1989;12(2):99-101.
1989: Ezio Ghigo; E Imperiale; E Mazza; S Goffi; Massimo Procopio; Eugenio E Müller; Franco Camanni
Cholinergic enhancement of pyridostigmine potentiates spontaneous diurnal but not nocturnal growth hormone secretion in short children.
Neuroendocrinology 1989;49(2):134-7.